Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Glucagon-like peptide 1 receptor antagonist PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Diabetes Mellitus, Type 2 3 D003924 ClinicalTrials
Hypoglycemia 2 D007003 ClinicalTrials
Obesity 2 D009765 ClinicalTrials
Nesidioblastosis 2 D046768 ClinicalTrials
Nutrition Disorders 1 D009748 ClinicalTrials
Congenital Hyperinsulinism 1 D044903 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297949
FDA SRS 5313W10MYT